Buprenorphine 400microgram sublingual tablets sugar free
BNF presentation 0407020B0AAADAD within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020B0AAADAD
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
10,615
NHS spend (£)
£96,324.75
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 1,267 |
| February 2025 | 39 |
| December 2024 | 490 |
| November 2024 | 1,392 |
| October 2024 | 1,410 |
| September 2024 | 7 |
| August 2024 | 167 |
| July 2024 | 1,332 |
| June 2024 | 17 |
| May 2024 | 531 |
| July 2021 | 676 |
| June 2021 | 661 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 90 | No data available |
| Unknown pharmacy | 74 | No data available |
| Unknown pharmacy | 65 | No data available |
| Unknown pharmacy | 65 | No data available |
| Unknown pharmacy | 61 | No data available |
| Unknown pharmacy | 60 | No data available |
| Unknown pharmacy | 57 | No data available |
| Unknown pharmacy | 55 | No data available |
| Unknown pharmacy | 54 | No data available |
| Unknown pharmacy | 50 | No data available |